Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03110354
Title DS-3201b for Acute Myelogenous Leukemia (AML) or Acute Lymphocytic Leukemia (ALL)
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Daiichi Sankyo Inc.
Indications

acute myeloid leukemia

acute lymphoblastic leukemia

Therapies

DS-3201b

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.